Two Sigma Securities, LLC Cyclo Therapeutics, Inc. Transaction History
Two Sigma Securities, LLC
- $716 Million
- Q4 2024
A detailed history of Two Sigma Securities, LLC transactions in Cyclo Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 42,541 shares of CYTH stock, worth $39,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,541Holding current value
$39,137% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CYTH
# of Institutions
21Shares Held
2.24MCall Options Held
0Put Options Held
0-
Epiq Capital Group, LLC San Francisco, CA689KShares$634,2910.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA599KShares$550,7980.0% of portfolio
-
Founders Fund V Management, LLC San Francisco, CA481KShares$442,25116.84% of portfolio
-
Geode Capital Management, LLC Boston, MA152KShares$140,1450.0% of portfolio
-
Founders Fund Vi Management, LLC San Francisco, CA110KShares$101,221100.0% of portfolio
About Cyclo Therapeutics, Inc.
- Ticker CYTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 8,439,440
- Market Cap $7.76M
- Description
- Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...